用于预测人体和大鼠口服剂量吸收分数的肠道通透性方法的验证。 - Suppr | 超能文献

The validation of the intestinal permeability approach to predict oral fraction of dose absorbed in humans and rats.

作者信息

Soria I, Zimmerman C L

出版信息

Biopharm Drug Dispos. 1996 Dec;17(9):817-8. doi: 10.1002/(SICI)1099-081X(199612)17:9<817::AID-BDD991>3.0.CO;2-M.

DOI:10.1002/(SICI)1099-081X(199612)17:9<817::AID-BDD991>3.0.CO;2-M

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

The validation of the intestinal permeability approach to predict oral fraction of dose absorbed in humans and rats.用于预测人体和大鼠口服剂量吸收分数的肠道通透性方法的验证。

Biopharm Drug Dispos. 1996 Dec;17(9):817-8. doi: 10.1002/(SICI)1099-081X(199612)17:9<817::AID-BDD991>3.0.CO;2-M.

2

The validation of the intestinal permeability approach to predict oral fraction of dose absorbed in humans and rats.验证肠道通透性方法以预测人和大鼠口服剂量的吸收分数。

Biopharm Drug Dispos. 1995 Jan;16(1):71-5. doi: 10.1002/bdd.2510160107.

3

In vivo bioavailability predictions from perfused intestine studies.基于灌注肠研究的体内生物利用度预测。

Int J Clin Pharmacol Ther. 1996 Feb;34(2):90-1.

4

Intestinal absorption of (-)-carbovir in the rat.大鼠体内（-）-卡波韦的肠道吸收

Pharm Res. 1994 Feb;11(2):267-71. doi: 10.1023/a:1018911609410.

5

Comparative bioavailability of two atenolol tablet formulations in healthy male volunteers after a single dose administration.单次给药后两种阿替洛尔片剂制剂在健康男性志愿者中的相对生物利用度。

Int J Clin Pharmacol Ther. 1997 Aug;35(8):324-8.

6

Absorption barriers in the rat intestinal mucosa. 3: Effects of polyethoxylated solubilizing agents on drug permeation and metabolism.大鼠肠黏膜中的吸收屏障。3：聚氧乙烯化增溶剂对药物渗透和代谢的影响。

J Pharm Sci. 2010 Feb;99(2):1016-27. doi: 10.1002/jps.21836.

7

Lack of effect of catheterization on the pharmacokinetics of (-)-carbovir in rats.导尿对大鼠体内（-）-卡波韦药代动力学无影响。

Pharm Res. 1996 Sep;13(9):1417-8. doi: 10.1023/a:1016094521668.

8

Dose-dependent intestinal absorption and significant intestinal excretion (exsorption) of the beta-blocker pafenolol in the rat.大鼠体内β受体阻滞剂帕非洛尔的剂量依赖性肠道吸收及显著的肠道排泄（反向吸收）

Pharm Res. 1993 May;10(5):727-31. doi: 10.1023/a:1018916017723.

9

Direct demonstration of small intestinal secretion and site-dependent absorption of the beta-blocker talinolol in humans.在人体中直接证明小肠对β受体阻滞剂他林洛尔的分泌及部位依赖性吸收。

Clin Pharmacol Ther. 1996 May;59(5):541-9. doi: 10.1016/S0009-9236(96)90182-4.

10

Dose proportional absorption of 25-150 mg atenolol.

Eur J Clin Pharmacol. 1993;44(3):305-6. doi: 10.1007/BF00271380.

引用本文的文献

1

Effects of lipid-based oral formulations on plasma and tissue amphotericin B concentrations and renal toxicity in male rats.脂质口服制剂对雄性大鼠血浆和组织中两性霉素B浓度及肾毒性的影响。

Antimicrob Agents Chemother. 2003 Oct;47(10):3339-42. doi: 10.1128/AAC.47.10.3339-3342.2003.